2m 2m 2m 2m 2m 2m 2m
CELLDEX THERAPTC (CLDX)
NASDAQ
$30.17-$0.48 (-1.58%)
Price as of Nov 11, 2026 7:02 PM EST- $2.4BMarket Cap
- 25.77%1-Year Change
- BiotechnologyIndustry
CELLDEX THERAPTC (CLDX)
$30.17-$0.48 (-1.58%)
CLDX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $30.65 | ||
Change | -$0.59 (-1.89%) | ||
Open | $31.10 | ||
High | $31.71 | ||
Low | $30.52 | ||
Previous Close | $31.24 | ||
Volume | 820,673 | ||
30-Day Average Volume | 1,041,043 | ||
1-Week Change | 3.16% | ||
1-Month Change | 2.54% | ||
1-Year Change | 25.77% | ||
3-Year Change | 13.77% | ||
5-Year Change | -32.95% | ||
Fundamentals | |||
Shares Outstanding | 78.5M | ||
Total Assets | $721.5M | ||
Market Cap | $2.4B | ||
Enterprise Value | $2.4B | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$75.6M | ||
Free Cash Flow | -$66.7M | ||
EBIT | -$75.6M | ||
EBITDA | -$74.4M | ||
Net Working Capital | $603.2M | ||
EPS | -$0.96 | ||
Enterprise Value/EBITDA | -32 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 4 | ||
P/E | -32 | ||
PEG | 15 | ||
Price/Free Cash Flow | -36 | ||
Price/Operating Cash Flow | -37 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 15 | ||
Last Split Date | 02/11/2019 | ||
Earnings & Revenue